{"pmid":32259477,"title":"Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.","text":["Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.","The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and rapidly spread worldwide. To prevent SARS-CoV-2 dissemination, understanding the in vivo characteristics of SARS-CoV-2 is a high priority. We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease. SARS-CoV-2-infected ferrets exhibit elevated body temperatures and virus replication. Although fatalities were not observed, SARS-CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection. At 2 days post-contact, SARS-CoV-2 was detected in all naive direct contact ferrets. Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission. Viral antigens were detected in nasal turbinate, trachea, lungs, and intestine with acute bronchiolitis present in infected lungs. Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines.","Cell Host Microbe","Kim, Young-Il","Kim, Seong-Gyu","Kim, Se-Mi","Kim, Eun-Ha","Park, Su-Jin","Yu, Kwang-Min","Chang, Jae-Hyung","Kim, Eun Ji","Lee, Seunghun","Casel, Mark Anthony B","Um, Jihye","Song, Min-Suk","Jeong, Hye Won","Lai, Van Dam","Kim, Yeonjae","Chin, Bum Sik","Park, Jun-Sun","Chung, Ki-Hyun","Foo, Suan-Sin","Poo, Haryoung","Mo, In-Pil","Lee, Ok-Jun","Webby, Richard J","Jung, Jae U","Choi, Young Ki","32259477"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and rapidly spread worldwide. To prevent SARS-CoV-2 dissemination, understanding the in vivo characteristics of SARS-CoV-2 is a high priority. We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease. SARS-CoV-2-infected ferrets exhibit elevated body temperatures and virus replication. Although fatalities were not observed, SARS-CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection. At 2 days post-contact, SARS-CoV-2 was detected in all naive direct contact ferrets. Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission. Viral antigens were detected in nasal turbinate, trachea, lungs, and intestine with acute bronchiolitis present in infected lungs. Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines."],"journal":"Cell Host Microbe","authors":["Kim, Young-Il","Kim, Seong-Gyu","Kim, Se-Mi","Kim, Eun-Ha","Park, Su-Jin","Yu, Kwang-Min","Chang, Jae-Hyung","Kim, Eun Ji","Lee, Seunghun","Casel, Mark Anthony B","Um, Jihye","Song, Min-Suk","Jeong, Hye Won","Lai, Van Dam","Kim, Yeonjae","Chin, Bum Sik","Park, Jun-Sun","Chung, Ki-Hyun","Foo, Suan-Sin","Poo, Haryoung","Mo, In-Pil","Lee, Ok-Jun","Webby, Richard J","Jung, Jae U","Choi, Young Ki"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259477","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.chom.2020.03.023","keywords":["2019-nCoV","2019-novel coronavirus","COVID-19","SARS-CoV-2","ferrets","novel coronavirus disease","severe acute respiratory syndrome coronavirus 2","transmission","virus shedding"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1663450393434128384,"score":7.9164424,"similar":[{"pmid":32269068,"title":"Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.","text":["Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the infectious disease COVID-19, which was first reported in Wuhan, China in December, 2019. Despite the tremendous efforts to control the disease, COVID-19 has now spread to over 100 countries and caused a global pandemic. SARS-CoV-2 is thought to have originated in bats; however, the intermediate animal sources of the virus are completely unknown. Here, we investigated the susceptibility of ferrets and animals in close contact with humans to SARS-CoV-2. We found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but ferrets and cats are permissive to infection. We found experimentally that cats are susceptible to airborne infection. Our study provides important insights into the animal models for SARS-CoV-2 and animal management for COVID-19 control.","Science","Shi, Jianzhong","Wen, Zhiyuan","Zhong, Gongxun","Yang, Huanliang","Wang, Chong","Huang, Baoying","Liu, Renqiang","He, Xijun","Shuai, Lei","Sun, Ziruo","Zhao, Yubo","Liu, Peipei","Liang, Libin","Cui, Pengfei","Wang, Jinliang","Zhang, Xianfeng","Guan, Yuntao","Tan, Wenjie","Wu, Guizhen","Chen, Hualan","Bu, Zhigao","32269068"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the infectious disease COVID-19, which was first reported in Wuhan, China in December, 2019. Despite the tremendous efforts to control the disease, COVID-19 has now spread to over 100 countries and caused a global pandemic. SARS-CoV-2 is thought to have originated in bats; however, the intermediate animal sources of the virus are completely unknown. Here, we investigated the susceptibility of ferrets and animals in close contact with humans to SARS-CoV-2. We found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but ferrets and cats are permissive to infection. We found experimentally that cats are susceptible to airborne infection. Our study provides important insights into the animal models for SARS-CoV-2 and animal management for COVID-19 control."],"journal":"Science","authors":["Shi, Jianzhong","Wen, Zhiyuan","Zhong, Gongxun","Yang, Huanliang","Wang, Chong","Huang, Baoying","Liu, Renqiang","He, Xijun","Shuai, Lei","Sun, Ziruo","Zhao, Yubo","Liu, Peipei","Liang, Libin","Cui, Pengfei","Wang, Jinliang","Zhang, Xianfeng","Guan, Yuntao","Tan, Wenjie","Wu, Guizhen","Chen, Hualan","Bu, Zhigao"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269068","week":"202015|Apr 06 - Apr 12","doi":"10.1126/science.abb7015","source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1663620082979307520,"score":413.70523},{"pmid":32215622,"title":"Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility.","text":["Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility.","BACKGROUND: A physiological small animal model that resembles COVID-19 with low mortality is lacking. METHODS: Molecular docking on the binding between angiotensin-converting enzyme 2 (ACE2) of common laboratory mammals and the receptor-binding domain of the surface spike protein of SARS-CoV-2 suggested that the golden Syrian hamster is an option. Virus challenge, contact transmission, and passive immunoprophylaxis were performed. Serial organ tissues and blood were harvested for histopathology, viral load and titre, chemokine/cytokine assay, and neutralising antibody titre. RESULTS: The Syrian hamster could be consistently infected by SARS-CoV-2. Maximal clinical signs of rapid breathing, weight loss, histopathological changes from the initial exudative phase of diffuse alveolar damage with extensive apoptosis to the later proliferative phase of tissue repair, airway and intestinal involvement with virus nucleocapsid protein expression, high lung viral load, and spleen and lymphoid atrophy associated with marked cytokine activation were observed within the first week of virus challenge. The lung virus titre was between 105-107 TCID50/g. Challenged index hamsters consistently infected naive contact hamsters housed within the same cage, resulting in similar pathology but not weight loss. All infected hamsters recovered and developed mean serum neutralising antibody titre >/=1:427 fourteen days post-challenge. Immunoprophylaxis with early convalescent serum achieved significant decrease in lung viral load but not in lung pathology. No consistent non-synonymous adaptive mutation of the spike was found in viruses isolated from infected hamsters. CONCLUSIONS: Besides satisfying the Koch's postulates, this readily available hamster model is an important tool for studying transmission, pathogenesis, treatment, and vaccination against SARS-CoV-2.","Clin Infect Dis","Chan, Jasper Fuk-Woo","Zhang, Anna Jinxia","Yuan, Shuofeng","Poon, Vincent Kwok-Man","Chan, Chris Chung-Sing","Lee, Andrew Chak-Yiu","Chan, Wan-Mui","Fan, Zhimeng","Tsoi, Hoi-Wah","Wen, Lei","Liang, Ronghui","Cao, Jianli","Chen, Yanxia","Tang, Kaiming","Luo, Cuiting","Cai, Jian-Piao","Kok, Kin-Hang","Chu, Hin","Chan, Kwok-Hung","Sridhar, Siddharth","Chen, Zhiwei","Chen, Honglin","To, Kelvin Kai-Wang","Yuen, Kwok-Yung","32215622"],"abstract":["BACKGROUND: A physiological small animal model that resembles COVID-19 with low mortality is lacking. METHODS: Molecular docking on the binding between angiotensin-converting enzyme 2 (ACE2) of common laboratory mammals and the receptor-binding domain of the surface spike protein of SARS-CoV-2 suggested that the golden Syrian hamster is an option. Virus challenge, contact transmission, and passive immunoprophylaxis were performed. Serial organ tissues and blood were harvested for histopathology, viral load and titre, chemokine/cytokine assay, and neutralising antibody titre. RESULTS: The Syrian hamster could be consistently infected by SARS-CoV-2. Maximal clinical signs of rapid breathing, weight loss, histopathological changes from the initial exudative phase of diffuse alveolar damage with extensive apoptosis to the later proliferative phase of tissue repair, airway and intestinal involvement with virus nucleocapsid protein expression, high lung viral load, and spleen and lymphoid atrophy associated with marked cytokine activation were observed within the first week of virus challenge. The lung virus titre was between 105-107 TCID50/g. Challenged index hamsters consistently infected naive contact hamsters housed within the same cage, resulting in similar pathology but not weight loss. All infected hamsters recovered and developed mean serum neutralising antibody titre >/=1:427 fourteen days post-challenge. Immunoprophylaxis with early convalescent serum achieved significant decrease in lung viral load but not in lung pathology. No consistent non-synonymous adaptive mutation of the spike was found in viruses isolated from infected hamsters. CONCLUSIONS: Besides satisfying the Koch's postulates, this readily available hamster model is an important tool for studying transmission, pathogenesis, treatment, and vaccination against SARS-CoV-2."],"journal":"Clin Infect Dis","authors":["Chan, Jasper Fuk-Woo","Zhang, Anna Jinxia","Yuan, Shuofeng","Poon, Vincent Kwok-Man","Chan, Chris Chung-Sing","Lee, Andrew Chak-Yiu","Chan, Wan-Mui","Fan, Zhimeng","Tsoi, Hoi-Wah","Wen, Lei","Liang, Ronghui","Cao, Jianli","Chen, Yanxia","Tang, Kaiming","Luo, Cuiting","Cai, Jian-Piao","Kok, Kin-Hang","Chu, Hin","Chan, Kwok-Hung","Sridhar, Siddharth","Chen, Zhiwei","Chen, Honglin","To, Kelvin Kai-Wang","Yuen, Kwok-Yung"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32215622","week":"202013|Mar 23 - Mar 29","doi":"10.1093/cid/ciaa325","keywords":["COVID-19","SARS-CoV-2","animal","coronavirus","transmission"],"source":"PubMed","locations":["Syrian"],"countries":["Syrian Arab Republic"],"countries_codes":["SYR|Syrian Arab Republic"],"topics":["Transmission","Diagnosis"],"weight":1,"_version_":1663352134997901312,"score":221.93227},{"pmid":32270371,"title":"Coronavirus: Update Related to the Current Outbreak of COVID-19.","text":["Coronavirus: Update Related to the Current Outbreak of COVID-19.","In December 2019, some cases of viral pneumonia were epidemiologically related to a new coronavirus in the province of Hubei, China. Subsequently, there has been an increase in infections attributable to this virus throughout China and worldwide. The World Health Organization (WHO) has officially named the infection coronavirus disease 2019 (COVID-19), and the virus has been classified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This appears to be a virus from Rhinolophus bats, but the intermediate host has not yet been identified. The mechanism of infection of SARS-CoV-2 is not yet known; it appears to have affinity for cells located in the lower airways, where it replicates. The interhuman transmission of coronaviruses mainly occurs through saliva droplets and direct and indirect contact via surfaces. As of March 10, 2020, the number of cases worldwide was 113,702. Along with severe acute respiratory syndrome (SARS) and Middle Eastern respiratory syndrome (MERS), COVID-19 appears to cause a severe clinical picture in humans, ranging from mild malaise to death by sepsis/acute respiratory distress syndrome. The prognosis is worse in elderly patients with comorbidities. To date, there is no specific therapy for COVID-19. Prevention of SARS-CoV-2 infection implies strategies that limit the spread of the virus. WHO and other international and national bodies have developed continuously updated strategic objectives and provisions to contain the spread of the virus and infection.","Infect Dis Ther","Gabutti, Giovanni","d'Anchera, Erica","Sandri, Federica","Savio, Marta","Stefanati, Armando","32270371"],"abstract":["In December 2019, some cases of viral pneumonia were epidemiologically related to a new coronavirus in the province of Hubei, China. Subsequently, there has been an increase in infections attributable to this virus throughout China and worldwide. The World Health Organization (WHO) has officially named the infection coronavirus disease 2019 (COVID-19), and the virus has been classified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This appears to be a virus from Rhinolophus bats, but the intermediate host has not yet been identified. The mechanism of infection of SARS-CoV-2 is not yet known; it appears to have affinity for cells located in the lower airways, where it replicates. The interhuman transmission of coronaviruses mainly occurs through saliva droplets and direct and indirect contact via surfaces. As of March 10, 2020, the number of cases worldwide was 113,702. Along with severe acute respiratory syndrome (SARS) and Middle Eastern respiratory syndrome (MERS), COVID-19 appears to cause a severe clinical picture in humans, ranging from mild malaise to death by sepsis/acute respiratory distress syndrome. The prognosis is worse in elderly patients with comorbidities. To date, there is no specific therapy for COVID-19. Prevention of SARS-CoV-2 infection implies strategies that limit the spread of the virus. WHO and other international and national bodies have developed continuously updated strategic objectives and provisions to contain the spread of the virus and infection."],"journal":"Infect Dis Ther","authors":["Gabutti, Giovanni","d'Anchera, Erica","Sandri, Federica","Savio, Marta","Stefanati, Armando"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270371","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s40121-020-00295-5","keywords":["COVID-19","Coronavirus","Infectious disease","MERS","Pneumonia","Public health","SARS","SARS-COV-2"],"source":"PubMed","locations":["China","Rhinolophus","Hubei","Middle Eastern"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis","Treatment","Prevention","Transmission"],"weight":1,"_version_":1663620082976161792,"score":183.0389},{"pmid":32243607,"title":"The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.","text":["The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.","BACKGROUND: In December 2019, Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, and has spread globally. However, the transmission route of SARS-CoV-2 has not been fully understood. In this study, we aimed to investigate the SARS-CoV-2 shedding in excreta of COVID-19 patients. METHODS: Electronical medical records, including demographics, clinical characteristics, laboratory and radiological findings, of enrolled patients were extracted and analyzed. Pharyngeal swab, stool and urine specimens were collected and tested for SARS-CoV-2 RNA by RT-PCR. Viral shedding at multiple time points in specimens was recorded, and analyzed its correlation with clinical manifestations and the severity of illness. RESULTS: A total of 42 laboratory-confirmed patients were enrolled, 8 (19.05%) of whom had gastrointestinal symptoms. 28 (66.67%) patients tested positive for SARS-CoV-2 RNA in stool specimens, which was not associated with the presence of gastrointestinal symptoms and the severity of illness. Among them, 18 (64.29%) patients remained positive for viral RNA in feces after pharyngeal swabs turned negative. The duration of viral shedding from feces after negative conversion in pharyngeal swabs was 7 (6-10) days, regardless of COVID-19 severity. The demographics, clinical characteristics, laboratory and radiologic findings did no differ between patients tested positive and negative for SARS-CoV-2 RNA in feces. Viral RNA was not detectable in urine specimens from 10 patients. CONCLUSIONS: Our results demonstrated the presence of SARS-CoV-2 RNA in feces of COVID-19 patients, and suggested the possibility of SARS-CoV-2 transmission via the fecal-oral route. This article is protected by copyright. All rights reserved.","J Med Virol","Chen, Yifei","Chen, Liangjun","Deng, Qiaoling","Zhang, Guqin","Wu, Kaisong","Ni, Lan","Yang, Yibin","Liu, Bing","Wang, Wei","Wei, Chaojie","Yang, Jiong","Ye, Guangming","Cheng, Zhenshun","32243607"],"abstract":["BACKGROUND: In December 2019, Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, and has spread globally. However, the transmission route of SARS-CoV-2 has not been fully understood. In this study, we aimed to investigate the SARS-CoV-2 shedding in excreta of COVID-19 patients. METHODS: Electronical medical records, including demographics, clinical characteristics, laboratory and radiological findings, of enrolled patients were extracted and analyzed. Pharyngeal swab, stool and urine specimens were collected and tested for SARS-CoV-2 RNA by RT-PCR. Viral shedding at multiple time points in specimens was recorded, and analyzed its correlation with clinical manifestations and the severity of illness. RESULTS: A total of 42 laboratory-confirmed patients were enrolled, 8 (19.05%) of whom had gastrointestinal symptoms. 28 (66.67%) patients tested positive for SARS-CoV-2 RNA in stool specimens, which was not associated with the presence of gastrointestinal symptoms and the severity of illness. Among them, 18 (64.29%) patients remained positive for viral RNA in feces after pharyngeal swabs turned negative. The duration of viral shedding from feces after negative conversion in pharyngeal swabs was 7 (6-10) days, regardless of COVID-19 severity. The demographics, clinical characteristics, laboratory and radiologic findings did no differ between patients tested positive and negative for SARS-CoV-2 RNA in feces. Viral RNA was not detectable in urine specimens from 10 patients. CONCLUSIONS: Our results demonstrated the presence of SARS-CoV-2 RNA in feces of COVID-19 patients, and suggested the possibility of SARS-CoV-2 transmission via the fecal-oral route. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Chen, Yifei","Chen, Liangjun","Deng, Qiaoling","Zhang, Guqin","Wu, Kaisong","Ni, Lan","Yang, Yibin","Liu, Bing","Wang, Wei","Wei, Chaojie","Yang, Jiong","Ye, Guangming","Cheng, Zhenshun"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243607","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25825","keywords":["Coronavirus Disease 2019","Fecal-oral transmission","Severe Acute Respiratory Syndrome Coronavirus 2","Viral RNA","Viral shedding"],"source":"PubMed","locations":["Feces","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1663352135719321600,"score":179.01897},{"pmid":32235945,"title":"Virological assessment of hospitalized patients with COVID-2019.","text":["Virological assessment of hospitalized patients with COVID-2019.","Coronavirus disease 2019 (COVID-19) is an acute respiratory tract infection that emerged in late 2019(1,2). Initial outbreaks in China involved 13.8% cases with severe, and 6.1% with critical courses(3). This severe presentation corresponds to the usage of a virus receptor that is expressed predominantly in the lung(2,4). By causing an early onset of severe symptoms, this same receptor tropism is thought to have determined pathogenicity, but also aided the control, of severe acute respiratory syndrome (SARS) in 2003(5). However, there are reports of COVID-19 cases with mild upper respiratory tract symptoms, suggesting the potential for pre- or oligosymptomatic transmission(6-8). There is an urgent need for information on body site-specific virus replication, immunity, and infectivity. Here we provide a detailed virological analysis of nine cases, providing proof of active virus replication in upper respiratory tract tissues. Pharyngeal virus shedding was very high during the first week of symptoms (peak at 7.11 x 10(8) RNA copies per throat swab, day 4). Infectious virus was readily isolated from throat- and lung-derived samples, but not from stool samples, in spite of high virus RNA concentration. Blood and urine never yielded virus. Active replication in the throat was confirmed by viral replicative RNA intermediates in throat samples. Sequence-distinct virus populations were consistently detected in throat and lung samples from the same patient, proving independent replication. Shedding of viral RNA from sputum outlasted the end of symptoms. Seroconversion occurred after 7 days in 50% of patients (14 days in all), but was not followed by a rapid decline in viral load. COVID-19 can present as a mild upper respiratory tract illness. Active virus replication in the upper respiratory tract puts the prospects of COVID-19 containment in perspective.","Nature","Wolfel, Roman","Corman, Victor M","Guggemos, Wolfgang","Seilmaier, Michael","Zange, Sabine","Muller, Marcel A","Niemeyer, Daniela","Jones, Terry C","Vollmar, Patrick","Rothe, Camilla","Hoelscher, Michael","Bleicker, Tobias","Brunink, Sebastian","Schneider, Julia","Ehmann, Rosina","Zwirglmaier, Katrin","Drosten, Christian","Wendtner, Clemens","32235945"],"abstract":["Coronavirus disease 2019 (COVID-19) is an acute respiratory tract infection that emerged in late 2019(1,2). Initial outbreaks in China involved 13.8% cases with severe, and 6.1% with critical courses(3). This severe presentation corresponds to the usage of a virus receptor that is expressed predominantly in the lung(2,4). By causing an early onset of severe symptoms, this same receptor tropism is thought to have determined pathogenicity, but also aided the control, of severe acute respiratory syndrome (SARS) in 2003(5). However, there are reports of COVID-19 cases with mild upper respiratory tract symptoms, suggesting the potential for pre- or oligosymptomatic transmission(6-8). There is an urgent need for information on body site-specific virus replication, immunity, and infectivity. Here we provide a detailed virological analysis of nine cases, providing proof of active virus replication in upper respiratory tract tissues. Pharyngeal virus shedding was very high during the first week of symptoms (peak at 7.11 x 10(8) RNA copies per throat swab, day 4). Infectious virus was readily isolated from throat- and lung-derived samples, but not from stool samples, in spite of high virus RNA concentration. Blood and urine never yielded virus. Active replication in the throat was confirmed by viral replicative RNA intermediates in throat samples. Sequence-distinct virus populations were consistently detected in throat and lung samples from the same patient, proving independent replication. Shedding of viral RNA from sputum outlasted the end of symptoms. Seroconversion occurred after 7 days in 50% of patients (14 days in all), but was not followed by a rapid decline in viral load. COVID-19 can present as a mild upper respiratory tract illness. Active virus replication in the upper respiratory tract puts the prospects of COVID-19 containment in perspective."],"journal":"Nature","authors":["Wolfel, Roman","Corman, Victor M","Guggemos, Wolfgang","Seilmaier, Michael","Zange, Sabine","Muller, Marcel A","Niemeyer, Daniela","Jones, Terry C","Vollmar, Patrick","Rothe, Camilla","Hoelscher, Michael","Bleicker, Tobias","Brunink, Sebastian","Schneider, Julia","Ehmann, Rosina","Zwirglmaier, Katrin","Drosten, Christian","Wendtner, Clemens"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235945","week":"202014|Mar 30 - Apr 05","doi":"10.1038/s41586-020-2196-x","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1663352135585103872,"score":165.22581}]}